MNPR
Monopar Therapeutics Inc
85.20$
-4.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -21.3% | -6.7% | +17.1% | -13.0% | +908.3% | -83.4% | +5.3% | +49.7% | +52.2% | -11.5% | +36.7% | – | |
| – | +16.9% | -13.6% | -13.1% | -10.2% | +94.7% | +37.3% | -4.7% | -0.1% | +47.3% | +78,396.2% | -99.9% | – | |
| – | -7.5% | -9.9% | +3.8% | -12.0% | +603.2% | -70.9% | +0.4% | +26.6% | +50.4% | -15.1% | +27.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -1,773.5% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.